RK

Rishi Kant Vishwakarma

Active Director Director DIN 11873110
DIN 11873110 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Rishi Kant Vishwakarma

Data last updated:

Rishi Kant Vishwakarma is a Director at Medkind Life Science Private Limited (since 2026) and Director/Designated Partner at Rivekanand Foundation (since 2026).

DIN 11873110
Primary Designation Director
First Appointment 18 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medkind Life Science Private Limited U46497UP2026PTC251632
Director19 Aug 20262026Active
Rivekanand Foundation U88900UP2026NPL251055
Director/Designated Partner18 Aug 20262026Active

Board colleagues of Rishi Kant Vishwakarma

Directorship timeline

Open interactive timeline →
Medkind Life Science Private Limited
Rivekanand Foundation
Premium access

Shareholding and investment profile for Rishi Kant Vishwakarma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rishi Kant Vishwakarma

Rishi Kant Vishwakarma currently holds 2 directorships: Medkind Life Science Private Limited (Director, since 19 Aug 2026); Rivekanand Foundation (Director/Designated Partner, since 18 Aug 2026).

Rishi Kant Vishwakarma was first appointed on 18 Aug 2026 as Director/Designated Partner at Rivekanand Foundation.

The current boards of Rishi Kant Vishwakarma's companies include Vivek Maurya (Medkind Life Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available